Suboptimal action of NF-kappaB in Fanconi anemia cells results from low levels of thioredoxin

Biol Chem. 2003 Oct-Nov;384(10-11):1501-7. doi: 10.1515/BC.2003.166.

Abstract

Electrophoretic mobility shift assays (EMSA) revealed that under standard cell culture conditions NF-kappaB was induced in Fanconi anemia fibroblasts in contrast to control cells. Dithiothreitol, a potent synthetic redox potential-delivering compound, when added to growing cells, prevented this induction of NF-kappaB and, simultaneously, chromosomal instability was reduced. Fanconi anemia cells possess low endogenous levels of the naturally occurring antioxidant thioredoxin. Transfection of Fanconi anemia cells with thioredoxin cDNA containing a nuclear localization signal prevented both spontaneous as well as mitomycin C-induced chromosomal instability. A promotor construct with two NF-kappaB binding sites in front of the CAT gene induced little CAT expression in cells with low thioredoxin content in spite of induced NF-kappaB. In cells with higher thioredoxin content CAT expression was increased. Cotransfection of the NF-kappaB-dependent CAT plasmid with the Trx/nuc-plasmid into FA fibroblasts increased the CAT expression to almost that of control cells, indicating that in this model system with diminished thioredoxin content NF-kappaB requires thioredoxin for binding to its specific promotor. Since Fanconi anemia cells have low thioredoxin contents, NF-kappaB-dependent genes are expressed insufficiently. This explains part of the pathophysiological processes observed in Fanconi anemia.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Cells, Cultured
  • Chloramphenicol O-Acetyltransferase / biosynthesis
  • Chloramphenicol O-Acetyltransferase / genetics
  • Chloramphenicol O-Acetyltransferase / metabolism*
  • Chromosomal Instability / drug effects
  • DNA, Complementary / chemistry
  • DNA, Complementary / metabolism
  • Dithiothreitol / pharmacology
  • Electrophoretic Mobility Shift Assay
  • Fanconi Anemia / drug therapy
  • Fanconi Anemia / metabolism*
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism*
  • Humans
  • NF-kappa B / biosynthesis
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • Oxidation-Reduction
  • Oxidative Stress
  • Plasmids
  • Promoter Regions, Genetic
  • Thioredoxins / analysis
  • Thioredoxins / genetics
  • Thioredoxins / metabolism*
  • Transfection

Substances

  • DNA, Complementary
  • NF-kappa B
  • Thioredoxins
  • Chloramphenicol O-Acetyltransferase
  • Dithiothreitol